Shah Capital Cuts Novavax Stake To 6.39%, Sells 2.87M Shares At Average Price Of $11.35/Share, Restructures Holdings Into Family Office
- SEC Filing
Filings · News reference
Shah Capital Filed To Voluntarily Withdraw Its Registration As An Investment Adviser With SEC, Effective Oct. 16; Shah Capital No Longer Holds Novavax Shares With Purpose Of Influencing Control, Intends To Report On Schedule 13G Going Forward
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Citigroup Maintains Sell on Novavax, Raises Price Target to $8
Citigroup analyst Geoff Meacham maintains Novavax (NASDAQ:NVAX) with a Sell and raises the price target from $7 to $8.
Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'
Stephen King slammed Trump’s incoming press secretary over her vaccine conspiracy theories and controversial posts.